Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Marksans Pharma Limited ( (IN:MARKSANS) ) just unveiled an announcement.
Marksans Pharma Limited has announced the appointment of M/s Jinesh Dedhia & Associates as the Secretarial Auditor for a five-year term starting from April 1, 2025, to March 31, 2030. This strategic move is part of the company’s compliance with regulatory requirements and aims to enhance its governance practices, potentially strengthening its market position and stakeholder confidence.
More about Marksans Pharma Limited
Marksans Pharma Limited is a company operating in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceutical products. The company serves various markets, including domestic and international sectors, with a range of therapeutic products.
Average Trading Volume: 100,455
Current Market Cap: 117.3B INR
For an in-depth examination of MARKSANS stock, go to TipRanks’ Overview page.